Curatis Holding AG | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
Curatis Holding AG

BRIEF

published on 11/14/2024 at 07:05, 7 days 6 hours ago

Curatis to Apply for Biologic License for C-PTBE-01 in the USA

Diffuse Midline Glioma Curatis Holding AG C-PTBE-01 Biologic License Application Market Protection
PRESS RELEASE

published on 11/14/2024 at 07:00, 7 days 6 hours ago

Curatis wird für C-PTBE-01 in den USA eine Biologic License beantragen - damit erhöht sich die Dauer des Marktschutzes in den USA markant im Falle einer Zulassung
Curatis Holding AG plans to apply for a Biologic License (BLA) for C-PTBE-01 in the USA, extending market protection significantly if approved

USA Curatis Holding AG C-PTBE-01 Biologic License Application Market Protection
BRIEF

published on 09/16/2024 at 07:05, 2 months 5 days ago

Curatis Shows Significant Revenue Growth and Progress in Development Pipeline

Revenue Growth FDA Submission H1 2024 Results Curatis Holding Product Pipeline
PRESS RELEASE

published on 09/16/2024 at 07:00, 2 months 5 days ago

Curatis: Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-Pipeline auf Kurs
Curatis Holding AG reports significantly increased revenue in core business and projects in development pipeline on track. Strong financial position and growth prospects highlighted in H1 2024 results

Financial Results Pharmaceutical Industry Revenue Business Development Curatis Holding AG
BRIEF

published on 09/12/2024 at 19:51, 2 months 8 days ago

Curatis Holding AG to Present at Investora and Release H1 Report Early

Half-year Report Orphan Drugs FDA Submission Curatis Holding Investora Conference
PRESS RELEASE

published on 09/12/2024 at 19:46, 2 months 8 days ago

Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September
Curatis Holding to participate in Investora on September 19, 2024, and release half-year report on September 16. Key executives to present the company at the conference

Conference Orphan Drugs Pharma Curatis Holding Investora
BRIEF

published on 08/27/2024 at 17:50, 2 months 24 days ago

Curatis on Track: Submits Orphan Drug Application for Key Product Candidate in the US

FDA Curatis Orphan Drug Brain Tumor Pediatric
PRESS RELEASE

published on 08/27/2024 at 17:45, 2 months 24 days ago

Curatis auf Kurs: Einreichung des Antrags für Orphan-Drug-Designation des wichtigsten Produktkandidaten in den USA
Curatis Holding AG submits application for Orphan Drug Designation of lead product candidate C-PBTE-01 in the USA, targeting rare brain tumors affecting children

Orphan Drug Designation Rare Disease Curatis Holding AG C-PBTE-01 Childhood Cancer
BRIEF

published on 07/25/2024 at 07:05, 3 months 27 days ago

Curatis Holding AG: Initiation of Coverage by valuationLAB

Curatis Equity Research Orphan Drugs ValuationLAB C-PTBE-01
PRESS RELEASE

published on 07/25/2024 at 07:00, 3 months 27 days ago

Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB
Curatis Holding AG has initiated coverage and published an equity research report by valuationLAB estimating a risk-adjusted net present value of CHF 20.00 per share, signaling an enterprise value of CHF 103 million

Initiation Of Coverage Curatis Holding AG ValuationLAB Equity Research Report CHF 20.00 Per Share

Accesswire

Published on 11/21/2024 at 13:00, 32 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 32 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 32 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 32 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 32 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 17 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 57 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 17 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 26 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 32 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 34 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 12 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 47 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 47 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE